Roy F. Chemaly, MD, MPH, FIDSA, FACP, and Genovefa Papanicolaou, MD, FIDSA, offer insight into managing CMV in HCT recipients in a new era of antiviral therapy in this CME activity titled “Changing the Paradigm of CMV Management: New Science and More Choices for Challenging Cases in the HCT Setting.” For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/ZXF865. CME credit will be available until March 19, 2021.
